Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Antibiotics and Staphylococcus aureus--more than meets the MIC.

Howden BP.

J Mol Med (Berl). 2014 Feb;92(2):103-6. doi: 10.1007/s00109-013-1113-2. No abstract available.

PMID:
24337505
2.

In vitro susceptibility patterns of methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococcus corneal isolates to antibiotics.

Elsahn AF, Yildiz EH, Jungkind DL, Abdalla YF, Erdurmus M, Cremona FA, Rapuano CJ, Hammersmith KM, Cohen EJ.

Cornea. 2010 Oct;29(10):1131-5. doi: 10.1097/ICO.0b013e3181d2ce25. Erratum in: Cornea. 2010 Dec;29(12):1470.

PMID:
20595899
3.

Antibiotic safety considerations in methicillin-resistant Staphylococcus aureus postpartum mastitis.

Farahnik B, Murase JE.

J Am Acad Dermatol. 2016 Oct;75(4):e149. doi: 10.1016/j.jaad.2016.04.042. No abstract available.

PMID:
27646759
4.

The need to assay the real MIC when making the decision to eradicate Staphylococcus aureus with vancomycin.

Tomczak H, Szałek E, Błażejewska W, Myczko K, Horla A, Grześkowiak E.

Postepy Hig Med Dosw (Online). 2013 Sep 4;67:921-5.

5.

Phenotypic expression of methicillin resistance in nosocomial Staphylococcus aureus.

Bhat GK, Jathana LS, Kumar A.

Indian J Med Microbiol. 2008 Oct-Dec;26(4):398-9. No abstract available.

6.

Methicillin-resistant and methicillin-susceptible community-acquired Staphylococcus aureus infection among children.

Gomes RT, Lyra TG, Alves NN, Caldas RM, Barberino MG, Nascimento-Carvalho CM.

Braz J Infect Dis. 2013 Sep-Oct;17(5):573-8. doi: 10.1016/j.bjid.2013.02.010. Epub 2013 Sep 19.

7.

Efficacy of NZ2114, a novel plectasin-derived cationic antimicrobial peptide antibiotic, in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.

Xiong YQ, Hady WA, Deslandes A, Rey A, Fraisse L, Kristensen HH, Yeaman MR, Bayer AS.

Antimicrob Agents Chemother. 2011 Nov;55(11):5325-30. doi: 10.1128/AAC.00453-11. Epub 2011 Aug 22.

8.

In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.

Mendes RE, Moet GJ, Janechek MJ, Jones RN.

Antimicrob Agents Chemother. 2010 Jun;54(6):2704-6. doi: 10.1128/AAC.00301-10. Epub 2010 Apr 12.

9.

Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil.

Panesso D, Planet PJ, Diaz L, Hugonnet JE, Tran TT, Narechania A, Munita JM, Rincon S, Carvajal LP, Reyes J, Londoño A, Smith H, Sebra R, Deikus G, Weinstock GM, Murray BE, Rossi F, Arthur M, Arias CA.

Emerg Infect Dis. 2015 Oct;21(10):1844-8. doi: 10.3201/eid2110.141914.

10.

Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.

Mottola C, Matias CS, Mendes JJ, Melo-Cristino J, Tavares L, Cavaco-Silva P, Oliveira M.

BMC Microbiol. 2016 Jun 23;16(1):119. doi: 10.1186/s12866-016-0737-0.

11.

Glycopeptides--important treatment option for methicillin-resistant Staphylococcus aureus.

Arora S, Arora U.

Indian J Med Microbiol. 2011 Jul-Sep;29(3):313-4. doi: 10.4103/0255-0857.83922. No abstract available.

12.

Differences in vancomycin minimum inhibitory concentrations for Staphylococcus aureus obtained with the automated Phoenix™ system, the Clinical and Laboratory Standards Institute broth microdilution method and the standard Etest.

Muñoz-Cobo B, Sancho-Tello S, Costa E, Bravo D, Torregrosa I, de Lomas JG, Navarro D.

Int J Antimicrob Agents. 2011 Mar;37(3):278-9. doi: 10.1016/j.ijantimicag.2010.12.004. Epub 2011 Jan 26. No abstract available.

PMID:
21269809
13.
14.

Growing Resistance to Vancomycin among Methicillin Resistant Staphylococcus Aureus Isolates from Different Clinical Samples.

Pahadi PC, Shrestha UT, Adhikari N, Shah PK, Amatya R.

JNMA J Nepal Med Assoc. 2014 Oct-Dec;52(196):977-81.

PMID:
26982895
15.

Should higher vancomycin trough levels be targeted for invasive community-acquired methicillin-resistant Staphylococcus aureus infections in children?

Jimenez-Truque N, Thomsen I, Saye E, Creech CB.

Pediatr Infect Dis J. 2010 Apr;29(4):368-70. doi: 10.1097/INF.0b013e3181c52a04.

16.

[Monitoring of the resistance to antibiotics of Staphylococcus aureus strains isolated from out-patients].

Văduva DB, Licker M, Dumitraşcu V, Văduva MB, Velimirovici D, Linţa M, Horhat F, Orb CE, Crăciunescu M, Branea D, Hogea E, Horhat D, Moldovan R.

Bacteriol Virusol Parazitol Epidemiol. 2005 Jan-Jun;50(1-2):41-8. Romanian. No abstract available.

PMID:
17300030
17.

Transconjunctival orbital invasion by methicillin-resistant Staphylococcus aureus.

Brown SM, Raflo GT, Fanning WL.

Arch Ophthalmol. 2009 Jul;127(7):941-2. doi: 10.1001/archophthalmol.2009.144. No abstract available.

PMID:
19597122
18.

Beyond conventional antibiotics for the future treatment of methicillin-resistant Staphylococcus aureus infections: two novel alternatives.

Fitzgerald-Hughes D, Devocelle M, Humphreys H.

FEMS Immunol Med Microbiol. 2012 Aug;65(3):399-412. doi: 10.1111/j.1574-695X.2012.00954.x. Epub 2012 Apr 4. Review.

19.

Vancomycin minimum inhibitory concentrations and outcome in patients with severe Staphylococcus aureus infection.

Gould IM.

J Infect Dis. 2012 Mar 1;205(5):864-5; author reply 865-6. doi: 10.1093/infdis/jir848. Epub 2012 Jan 11. No abstract available.

PMID:
22238463
20.

Relationship between vancomycin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, high vancomycin MIC, and outcome in serious S. aureus infections.

Holmes NE, Johnson PD, Howden BP.

J Clin Microbiol. 2012 Aug;50(8):2548-52. doi: 10.1128/JCM.00775-12. Epub 2012 May 16. Review.

Supplemental Content

Support Center